Bulk Manufacturer of Controlled Substances Application: Organic Consultants LLC DBA Cascade Chemistry, 8718 [2025-02008]

Download as PDF 8718 Federal Register / Vol. 90, No. 20 / Friday, January 31, 2025 / Notices Melbourne, FL; FlexCompute Inc., Watertown, MA; MPI America Inc., San Jose, CA; Phlotonics, Inc., Rochester, NY; PICadvanced US LLC, Fort Lauderdale, FL; and Research Foundation on behalf of the University at Albany, Albany, NY, have been added as parties to this venture. Also, AAYUNA Inc., Allentown, PA; Trustees of Boston University, Boston, MA; Ebara Technologies, Inc., Sacramento, CA; George Washington University, Washington, DC; Presco Engineering, Woodbridge, CT; Teledyne Princeton Instruments, Trenton, NJ; and Milkshake Technology Inc., Menlo Park, CA, have withdrawn as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and AIM Photonics intends to file additional written notifications disclosing all changes in membership. On June 16, 2016, AIM Photonics filed its original notification pursuant to section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to section 6(b) of the Act on July 25, 2016 (81 FR 48450). The last notification was filed with the Department on July 1, 2024. A notice was published in the Federal Register pursuant to section 6(b) of the Act on September 26, 2024 (89 FR 78903). Suzanne Morris, Deputy Director Civil Enforcement Operations, Antitrust Division. the issuance of the proposed registration on or before April 1, 2025. Such persons may also file a written request for a hearing on the application on or before April 1, 2025. The Drug Enforcement Administration requires that all comments be submitted electronically BILLING CODE P through the Federal eRulemaking Portal, which provides the ability to type short DEPARTMENT OF JUSTICE comments directly into the comment field on the web page or attach a file for Drug Enforcement Administration lengthier comments. Please go to https://www.regulations.gov and follow [Docket No. DEA–1481] the online instructions at that site for Bulk Manufacturer of Controlled submitting comments. Upon submission Substances Application: Organic of your comment, you will receive a Consultants LLC DBA Cascade Comment Tracking Number. Please be Chemistry aware that submitted comments are not instantaneously available for public AGENCY: Drug Enforcement view on https://www.regulations.gov. If Administration, Justice. you have received a Comment Tracking ACTION: Notice of application. Number, your comment has been successfully submitted and there is no SUMMARY: Organic Consultants LLC DBA need to resubmit the same comment. Cascade Chemistry has applied to be registered as a bulk manufacturer of SUPPLEMENTARY INFORMATION: In basic class(es) of controlled accordance with 21 CFR 1301.33(a), this substance(s). Refer to SUPPLEMENTARY is notice that on November 26, 2024, INFORMATION listed below for further Organic Consultants LLC DBA Cascade drug information. Chemistry, 90 North Polk Street, Suite DATES: Registered bulk manufacturers of 200, Eugene, Oregon 97402–4109 applied to be registered as a bulk the affected basic class(es), and manufacturer of the following basic applicants, therefore, may submit electronic comments on or objections to class(es) of controlled substance(s): ADDRESSES: [FR Doc. 2025–02044 Filed 1–30–25; 8:45 am] Controlled substance Drug code ddrumheller on DSK120RN23PROD with NOTICES1 Amphetamine ................................................................................................................................................................... Methylphenidate .............................................................................................................................................................. Codeine ........................................................................................................................................................................... Oxycodone ....................................................................................................................................................................... Hydromorphone ............................................................................................................................................................... Hydrocodone ................................................................................................................................................................... Meperidine ....................................................................................................................................................................... Meperidine intermediate-A .............................................................................................................................................. Meperidine intermediate-B .............................................................................................................................................. Meperidine intermediate-C .............................................................................................................................................. Methadone ....................................................................................................................................................................... Methadone intermediate .................................................................................................................................................. Morphine .......................................................................................................................................................................... Thebaine .......................................................................................................................................................................... Oxymorphone .................................................................................................................................................................. Noroxymorphone ............................................................................................................................................................. Fentanyl ........................................................................................................................................................................... The company plans to bulk manufacture small quantities of the listed controlled substances for internal use or for sale as analytical reference standard materials to its customers. No other activities for these drug codes are authorized for this registration. Matthew Strait, Deputy Assistant Administrator. [FR Doc. 2025–02008 Filed 1–30–25; 8:45 am] BILLING CODE P VerDate Sep<11>2014 18:17 Jan 30, 2025 Jkt 265001 Drug Enforcement Administration [Docket No. DEA–1483] Importer of Controlled Substances Application: Medi-Physics Inc. DBA GE Healthcare Drug Enforcement Administration, Justice. ACTION: Notice of application. PO 00000 Frm 00025 Fmt 4703 Sfmt 4703 II II II II II II II II II II II II II II II II II Medi-Physics Inc. DBA GE Healthcare has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. SUMMARY: DEPARTMENT OF JUSTICE AGENCY: 1100 1724 9050 9143 9150 9193 9230 9232 9233 9234 9250 9254 9300 9333 9652 9668 9801 Schedule Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before March 3, 2025. Such DATES: E:\FR\FM\31JAN1.SGM 31JAN1

Agencies

[Federal Register Volume 90, Number 20 (Friday, January 31, 2025)]
[Notices]
[Page 8718]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-02008]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-1481]


Bulk Manufacturer of Controlled Substances Application: Organic 
Consultants LLC DBA Cascade Chemistry

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Organic Consultants LLC DBA Cascade Chemistry has applied to 
be registered as a bulk manufacturer of basic class(es) of controlled 
substance(s). Refer to Supplementary Information listed below for 
further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants, therefore, may submit electronic comments on or 
objections to the issuance of the proposed registration on or before 
April 1, 2025. Such persons may also file a written request for a 
hearing on the application on or before April 1, 2025.

ADDRESSES: The Drug Enforcement Administration requires that all 
comments be submitted electronically through the Federal eRulemaking 
Portal, which provides the ability to type short comments directly into 
the comment field on the web page or attach a file for lengthier 
comments. Please go to https://www.regulations.gov and follow the 
online instructions at that site for submitting comments. Upon 
submission of your comment, you will receive a Comment Tracking Number. 
Please be aware that submitted comments are not instantaneously 
available for public view on https://www.regulations.gov. If you have 
received a Comment Tracking Number, your comment has been successfully 
submitted and there is no need to resubmit the same comment.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on November 26, 2024, Organic Consultants LLC DBA 
Cascade Chemistry, 90 North Polk Street, Suite 200, Eugene, Oregon 
97402-4109 applied to be registered as a bulk manufacturer of the 
following basic class(es) of controlled substance(s):

------------------------------------------------------------------------
        Controlled substance            Drug code          Schedule
------------------------------------------------------------------------
Amphetamine........................            1100  II
Methylphenidate....................            1724  II
Codeine............................            9050  II
Oxycodone..........................            9143  II
Hydromorphone......................            9150  II
Hydrocodone........................            9193  II
Meperidine.........................            9230  II
Meperidine intermediate-A..........            9232  II
Meperidine intermediate-B..........            9233  II
Meperidine intermediate-C..........            9234  II
Methadone..........................            9250  II
Methadone intermediate.............            9254  II
Morphine...........................            9300  II
Thebaine...........................            9333  II
Oxymorphone........................            9652  II
Noroxymorphone.....................            9668  II
Fentanyl...........................            9801  II
------------------------------------------------------------------------

    The company plans to bulk manufacture small quantities of the 
listed controlled substances for internal use or for sale as analytical 
reference standard materials to its customers. No other activities for 
these drug codes are authorized for this registration.

Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2025-02008 Filed 1-30-25; 8:45 am]
BILLING CODE P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.